For example, we and others have shown that mTOR inhibition attenuates chemotherapy-mediated cell death in colon and renal cell carcinoma cell lines [24, 39], and in certain genetic contexts, such as loss of TSC1/2 [18] or REDD1 [17]. This evidence concerns the gene DDIT4 and renal cell carcinoma.